Cargando…

5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers

SIMPLE SUMMARY: 5-aminolevulinic acid (5-ALA) is administered orally before brain tumor surgery to improve intraoperative visualization of tumor tissue. In comparison to most of the aggressive high-grade gliomas, only a few low-grade gliomas (LGG) demonstrate visible fluorescence during surgery. As...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosmann, Arthur, Millesi, Matthias, Wadiura, Lisa I., Kiesel, Barbara, Mercea, Petra A., Mischkulnig, Mario, Borkovec, Martin, Furtner, Julia, Roetzer, Thomas, Wolfsberger, Stefan, Phillips, Joanna J., Berghoff, Anna S., Hervey-Jumper, Shawn, Berger, Mitchel S., Widhalm, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196836/ https://www.ncbi.nlm.nih.gov/pubmed/34064222 http://dx.doi.org/10.3390/cancers13112540

Ejemplares similares

Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
por: Hosmann, Arthur, et al.
Publicado: (2021)

TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2020)

5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches
por: Kiesel, Barbara, et al.
Publicado: (2021)

Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2021)

High Interobserver Agreement in the Subjective Classification of 5‐Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas
por: Mischkulnig, Mario, et al.
Publicado: (2020)

The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers
por: Mischkulnig, Mario, et al.
Publicado: (2022)

Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years
por: Kiesel, Barbara, et al.
Publicado: (2021)

High Diagnostic Accuracy of Visible 5‐ALA Fluorescence in Meningioma Surgery According to Histopathological Analysis of Tumor Bulk and Peritumoral Tissue
por: Wadiura, Lisa I., et al.
Publicado: (2020)

Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases
por: Mercea, Petra A., et al.
Publicado: (2021)

Comparison of minimal detectable protoporphyrin IX concentrations with a loupe device and conventional 5-ALA fluorescence microscopy: an experimental study
por: Mischkulnig, Mario, et al.
Publicado: (2023)

The Evoked Potential Score for SSEP and BAEP—A Prognostic Marker for the Long-Term Neurological Outcome in Patients after Poor-Grade Subarachnoid Hemorrhage
por: Wadiura, Lisa I., et al.
Publicado: (2021)

Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis
por: Lang, Alexandra, et al.
Publicado: (2023)

Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2022)

Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment
por: Mischkulnig, Mario, et al.
Publicado: (2023)

SURG-13. EVALUATION OF 5-ALA FLUORESCENCE IN BRAIN METASTASES OF VARIOUS PRIMARY TUMORS: A MULTICENTER STUDY WITH EXPERIENCE IN 157 CASES
por: Mercea, Petra Andreea, et al.
Publicado: (2019)

High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI
por: Hangel, Gilbert, et al.
Publicado: (2020)

BIMG-04. MAPPING HETEROGENEITY OF HIGH-GRADE GLIOMA METABOLISM USING HIGH RESOLUTION 7T MRSI
por: Hangel, Gilbert, et al.
Publicado: (2021)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

5-ALA fluorescence in indeterminate grade gliomas
por: Müther, Michael, et al.
Publicado: (2022)

Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status
por: Grabner, Günther, et al.
Publicado: (2016)

The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence
por: Goryaynov, Sergey A., et al.
Publicado: (2019)

Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery
por: De Witt Hamer, Philip C, et al.
Publicado: (2021)

Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors
por: Erkkilä, Mikael T., et al.
Publicado: (2020)

In Reply: Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery
por: De Witt Hamer, Philip C, et al.
Publicado: (2021)

Involvement of White Matter Language Tracts in Glioma: Clinical Implications, Operative Management, and Functional Recovery After Injury
por: Aabedi, Alexander A., et al.
Publicado: (2022)

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement
por: Widhalm, Georg, et al.
Publicado: (2013)

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas
por: Ogino, Hirokazu, et al.
Publicado: (2022)

Domain Mapping and Deep Learning from Multiple MRI Clinical Datasets for Prediction of Molecular Subtypes in Low Grade Gliomas
por: Ali, Muhaddisa Barat, et al.
Publicado: (2020)

T2 FLAIR Hyperintensity Volume Is Associated With Cognitive Function and Quality of Life in Clinically Stable Patients With Lower Grade Gliomas
por: Luks, Tracy L., et al.
Publicado: (2022)

Editorial: Quality of care of glioma patients
por: Forster, Marie-Therese, et al.
Publicado: (2022)

Corrigendum: Editorial: Quality of care of glioma patients
por: Forster, Marie-Therese, et al.
Publicado: (2022)

DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study
por: Millesi, Matthias, et al.
Publicado: (2022)

Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature
por: Morshed, Ramin A., et al.
Publicado: (2021)

Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas
por: Autry, Adam W., et al.
Publicado: (2022)

THE USE OF 5-AMINOLEVULINIC ACID (5-ALA) IN HIGH-GRADE GLIOMA SURGERY, A SINGLE CANADIAN CENTER EXPERIENCE
por: LeBlanc, Félix, et al.
Publicado: (2023)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis
por: Zhang, John J Y, et al.
Publicado: (2020)

Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology
por: Pekmezci, Melike, et al.
Publicado: (2021)

Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review
por: Solomou, Georgios, et al.
Publicado: (2022)

Comment on Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540
por: Stummer, Walter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gfph8vdfajtsvud5d54vtdc34c